ContextLogic Inc. - Class A Common Stock (LOGC)
7.9000
0.00 (0.00%)
ContextLogic Inc. operates as a technology-driven company that focuses on enhancing the shopping experience for consumers by leveraging a unique platform
Its primary service is in the realm of e-commerce, where it connects buyers with a wide variety of products from numerous retailers through an intuitive interface. The company emphasizes personalized shopping experiences powered by data analytics and user engagement, aiming to simplify the purchasing process and provide value to both consumers and merchants. Through its innovative approach, ContextLogic fosters a dynamic online marketplace that promotes instant discovery and access to a diverse range of goods.
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
LOGC stock results show that ContextLogic missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 9, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · July 4, 2024
![](https://cdn.benzinga.com/files/images/story/2022/10/04/image31.jpeg?width=1200&height=800&fit=crop)
Gainers LogicBio Therapeutics, Inc. (NASDAQLOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.
Via Benzinga · October 4, 2022
Looking Into LogicBio Therapeutics's Recent Short Interestbenzinga.com
LogicBio Therapeutics's (NASDAQLOGC) short percent of float has fallen 62.5% since its last report. The company recently reported that it has 29 thousand shares sold short, which is 0.12% of all regular shares that are available for trading.
Via Benzinga · October 3, 2022
![](https://cdn.benzinga.com/files/images/story/2022/10/03/image32.jpeg?width=1200&height=800&fit=crop)
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing around 270 points on Monday.
Via Benzinga · October 3, 2022
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_18318.jpeg?width=1200&height=800&fit=crop)
Gainers
Via Benzinga · October 3, 2022
![](https://cdn.benzinga.com/files/images/story/2022/10/03/image-tesla4.jpg?width=1200&height=800&fit=crop)
Gainers LogicBio Therapeutics, Inc. (NASDAQLOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.
Via Benzinga · October 3, 2022
![](https://cdn.benzinga.com/files/images/story/2022/10/03/image20.jpg?width=1200&height=800&fit=crop)
U.S. stocks extended gains midway through trading, with the Dow Jones gaining more than 600 points on Monday.
Via Benzinga · October 3, 2022
![](https://investorplace.com/wp-content/uploads/2022/05/shortsqueeze1600-1024x576.png)
Investors are still interested in short squeeze stocks lately and we've got them covered with the ones to watch this week!
Via InvestorPlace · October 3, 2022
![](https://investorplace.com/wp-content/uploads/2019/10/aprn-stock.jpg)
Blue Apron (APRN) stock is sliding lower on Monday as investors react to its CFO leaving the company and plans for a stock sale.
Via InvestorPlace · October 3, 2022
![](https://investorplace.com/wp-content/uploads/2019/08/azn-stock-3.jpg)
LogicBio (LOGC) stock is seeing massive gains on Monday following news that AstraZeneca (AZN) subsidiary Alexion is acquiring the company.
Via InvestorPlace · October 3, 2022
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_18271.jpeg?width=1200&height=800&fit=crop)
Gainers LogicBio Therapeutics (NASDAQLOGC) shares moved upwards by 641.3% to $2.02 during Monday's pre-market session. The company's market cap stands at $66.5 million.
Via Benzinga · October 3, 2022
![](https://cdn.benzinga.com/files/images/story/2022/10/03/analysis-gfa0f763ea_1920.jpg?width=1200&height=800&fit=crop)
LogicBio Therapeutics Inc (NASDAQLOGC) shares are trading higher Monday after the company announced it will be acquired by AstraZeneca PLC NASDAQ: AZNNASDAQAZN)
Via Benzinga · October 3, 2022
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_17324.jpeg?width=1200&height=800&fit=crop)
Gainers Reshape Lifesciences (NASDAQRSLS) stock increased by 10.1% to $0.39 during Monday's after-market session. The company's market cap stands at $1.3 million.
Via Benzinga · September 19, 2022
![](https://cdn.benzinga.com/files/images/story/2022/08/15/image12.jpg?width=1200&height=800&fit=crop)
U.S. stocks traded higher toward the end of trading, with the Dow Jones around 170 points on Monday.
Via Benzinga · August 15, 2022
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_14792.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · August 15, 2022
![](https://cdn.benzinga.com/files/images/story/2022/08/17/image11.jpg?width=1200&height=800&fit=crop)
Gainers Eargo, Inc. (NASDAQEAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids.
Via Benzinga · August 17, 2022
![](https://cdn.benzinga.com/files/images/story/2022/08/16/image16.jpg?width=1200&height=800&fit=crop)
Gainers Magic Empire Global Limited (NASDAQMEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month.
Via Benzinga · August 16, 2022
![](https://cdn.benzinga.com/files/images/story/2022/08/15/image_2_0.jpg?width=1200&height=800&fit=crop)
U.S. stocks traded turned higher midway through trading, with the Dow Jones gaining more than 100 points on Monday.
Via Benzinga · August 15, 2022
![](https://cdn.benzinga.com/files/images/story/2022/08/15/image31.jpeg?width=1200&height=800&fit=crop)
Gainers Sunrise New Energy Co. Ltd. (NASDAQEPOW) shares jumped 118.2% to $4.4948. Sunrise New Energy said that the company changed its name from Global Internet of the People, Inc. to Sunrise New Energy effective as of August 10, 2022.
Via Benzinga · August 15, 2022
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8432.jpeg?width=1200&height=800&fit=crop)
LogicBio Therapeutics (NASDAQLOGC) reported its Q2 earnings results on Monday, August 15, 2022 at 08:00 AM. Here's what investors need to know about the announcement.
Via Benzinga · August 15, 2022
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_14619.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · August 11, 2022
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_13240.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · July 25, 2022
![](https://cdn.benzinga.com/files/images/story/2022/08/09/image_3.jpg?width=1200&height=800&fit=crop)
Gainers Helbiz, Inc. (NASDAQHLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday.
Via Benzinga · August 9, 2022